Agenus (AGEN)
(Delayed Data from NSDQ)
$5.36 USD
-0.16 (-2.90%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $5.34 -0.02 (-0.37%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Agenus Inc. has a market cap of $151.34M, which represents its share price of $5.52 multiplied by its outstanding shares number of 27.42M. As a small-cap company, AGEN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AGEN 5.36 -0.16(-2.90%)
Will AGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGEN
Zacks.com featured highlights include QuantumScape, Civeo and Agenus
QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration
AGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies
Other News for AGEN
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report | AGEN Stock News
Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral ...
Agenus unit, MiNK surges after peer-reviewed data for lead drug
12 Health Care Stocks Moving In Monday's Intraday Session
Agenus' BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward ...